Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.88
-0.1950-0.69%
Volume:1.51M
Turnover:42.19M
Market Cap:158.49B
PE:36.68
High:28.16
Open:28.11
Low:27.87
Close:28.07
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:2.57
T/O Rate:0.03%
Dividend:1.72
Dividend Rate:6.17%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.86
PE(LYR):20.43

Loading ...

Pfizer - Hympavzi Approved for Hemophilia a or B Patients 12+ With Inhibitors and Children 6-11

THOMSON REUTERS
·
Jun 08

Analysts Conflicted on These Healthcare Names: Cullinan Management (CGEM) and Pfizer (PFE)

TIPRANKS
·
Jun 08

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Incyte (INCY) and Pfizer (PFE)

TIPRANKS
·
Jun 08

Pfizer presents results from Phase 2b studies of berobenatide

TIPRANKS
·
Jun 08

MEDIA-Pfizer-partnered obesity drugmaker Hangzhou Sciwind Biosciences eyes deals outside China- Bloomberg News

Reuters
·
Jun 08

A new wave of weight-loss therapies aims to be better than today's GLP-1s

Dow Jones
·
Jun 07

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

Dow Jones
·
Jun 07

Pfizer Doubles Down on Vaccines and Cancer Ambitions

TIPRANKS
·
Jun 06

Robust Phase 2B Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s Glp-1 Ra Berobenatide

THOMSON REUTERS
·
Jun 06

Pfizer - Vesper-1 Shows Nearly 16% Weight Loss at 32 Weeks on 2.4 Mg Weekly Berobenatide

THOMSON REUTERS
·
Jun 06

Pfizer - Plans 10 Phase 3 Berobenatide Studies in 2026 as Part of 20+ Obesity Trials

THOMSON REUTERS
·
Jun 06

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Reuters
·
Jun 06

Pfizer’s New Infant Pneumococcal Vaccine Trial: What Investors Should Watch

TIPRANKS
·
Jun 06

How New Multi‑Tumor Oncology Data At Pfizer (PFE) Has Changed Its Investment Story

Simply Wall St.
·
Jun 05

Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Pfizer publishes transcript from Jefferies Global Healthcare Conference appearance

Reuters
·
Jun 05

Pfizer Expands Oncology Pipeline With New PF-08634404 Combo Trial in Advanced Lung Cancer

TIPRANKS
·
Jun 05

BRIEF-Chai Discovery Announces License Agreement With Pfizer To Accelerate Drug Discovery With AI

Reuters
·
Jun 04

Breckenridge Announces Launch of Tofacitinib Tablets, Generic Equivalent of Xeljanz® by Pfizer

THOMSON REUTERS
·
Jun 04

Southwest Securities Highlights Innovent Biologics' Strategic Collaboration with Pfizer to Accelerate Oncology Drug Development

Stock News
·
Jun 04